<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01417234</url>
  </required_header>
  <id_info>
    <org_study_id>102110</org_study_id>
    <nct_id>NCT01417234</nct_id>
  </id_info>
  <brief_title>Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds</brief_title>
  <official_title>Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KCI USA, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System&#xD;
      for the treatment of acute trauma and acute surgical excision wounds. The secondary purpose&#xD;
      will be to compare the prospective patients to retrospectively treated acute trauma wounds to&#xD;
      further evaluate efficacy and safety.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Closure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Percent of subjects with study wound deemed closed at 12 weeks&#xD;
1 wound is studied per participant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Wound Size Change</measure>
    <time_frame>Baseline and 4 weeks</time_frame>
    <description>Percent change in wound size from baseline to week 4 (Week 4 - baseline / baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Wound Size Change</measure>
    <time_frame>4 weeks and 8 weeks</time_frame>
    <description>Percent change in wound size from week 4 to week 8 (Week 8 - Week 4 / Week 4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Wound Size Change</measure>
    <time_frame>8 weeks and 12 weeks</time_frame>
    <description>Percent change in wound size from week 8 to week 12 (12 Weeks - 8 weeks / 8 weeks)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Trauma-related Wound</condition>
  <condition>Surgical Wound, Recent</condition>
  <arm_group>
    <arm_group_label>SNaP® Wound Care System</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SNaP® Wound Care System</intervention_name>
    <description>Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
    <arm_group_label>SNaP® Wound Care System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be selected from exisiting investigator patient population.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Trauma wound, pressure ulcer, post operative wound, colostomy take-down site, or other&#xD;
             acute wound deemed appropriate by study investigator(s) as the source of the wound on&#xD;
             any part of the body including head and neck, torso, and extremities&#xD;
&#xD;
          -  Wound &lt; 16 cm in greatest diameter&#xD;
&#xD;
          -  Subject ≥ 18 years of age&#xD;
&#xD;
          -  Exudate &lt; 25 ml/ day (estimate)&#xD;
&#xD;
          -  Female subjects of child-bearing potential must be willing to take a urine pregnancy&#xD;
             test prior to starting study&#xD;
&#xD;
          -  Subject is willing and able to sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Wound &gt; 45 days old&#xD;
&#xD;
          -  Wound-related cellulitis&#xD;
&#xD;
          -  Wound located in an area not amenable to forming an air-tight seal&#xD;
&#xD;
          -  Subject has untreated osteomyelitis&#xD;
&#xD;
          -  Subject is allergic to wound care products&#xD;
&#xD;
          -  Wound has exposed blood vessels not suitable for negative pressure therapy&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Subject is actively participating in other clinical trials that conflict with current&#xD;
             study&#xD;
&#xD;
          -  Subject has fistulas&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>41955</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 12, 2011</study_first_submitted>
  <study_first_submitted_qc>August 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2011</study_first_posted>
  <results_first_submitted>September 16, 2020</results_first_submitted>
  <results_first_submitted_qc>October 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 6, 2020</results_first_posted>
  <last_update_submitted>October 15, 2020</last_update_submitted>
  <last_update_submitted_qc>October 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SNaP® Wound Care System</title>
          <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Subject non-compliant</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SNaP® Wound Care System</title>
          <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" spread="11.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Wound Closure</title>
        <description>Percent of subjects with study wound deemed closed at 12 weeks&#xD;
1 wound is studied per participant</description>
        <time_frame>12 weeks</time_frame>
        <population>Per protocol population used for analysis. 3 subjects withdrew from study early due to non-compliance with study therapy and were not included in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>SNaP® Wound Care System</title>
            <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Closure</title>
          <description>Percent of subjects with study wound deemed closed at 12 weeks&#xD;
1 wound is studied per participant</description>
          <population>Per protocol population used for analysis. 3 subjects withdrew from study early due to non-compliance with study therapy and were not included in this analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Wound Size Change</title>
        <description>Percent change in wound size from baseline to week 4 (Week 4 - baseline / baseline)</description>
        <time_frame>Baseline and 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SNaP® Wound Care System</title>
            <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Wound Size Change</title>
          <description>Percent change in wound size from baseline to week 4 (Week 4 - baseline / baseline)</description>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-41" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Wound Size Change</title>
        <description>Percent change in wound size from week 4 to week 8 (Week 8 - Week 4 / Week 4)</description>
        <time_frame>4 weeks and 8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SNaP® Wound Care System</title>
            <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Wound Size Change</title>
          <description>Percent change in wound size from week 4 to week 8 (Week 8 - Week 4 / Week 4)</description>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.2" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Wound Size Change</title>
        <description>Percent change in wound size from week 8 to week 12 (12 Weeks - 8 weeks / 8 weeks)</description>
        <time_frame>8 weeks and 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SNaP® Wound Care System</title>
            <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Wound Size Change</title>
          <description>Percent change in wound size from week 8 to week 12 (12 Weeks - 8 weeks / 8 weeks)</description>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>SNaP® Wound Care System</title>
          <description>SNaP® Wound Care System: Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>VP, Global Clinical Development</name_or_title>
      <organization>KCI</organization>
      <phone>12102555595</phone>
      <email>jane.hart@acelity.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

